Abstract
We aimed to investigate anxiety, depression and sexual satisfaction levels of testicular cancer survivors (TCSs) and compare the scores with healthy men’s. The Hospital Anxiety and Depression Scale (HADS), Golombok-Rust Inventory of Sexual Satisfaction (GRISS) and European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 were used. Forty-one TCSs and thirty-eight healthy men were participated in this study. The total HADs scores of TCSs (12.21 ± 8.19) were less than the healthy group (14.44 ± 6.53; p > 0.05). The high depression scores rate was 29.2 and 55.2, and high anxiety scores rate was 24.4 and 28.9 for TCSs and healthy group, respectively. When we evaluated GRISS subscores and anxiety levels, we found significantly increase only in avoidance subscores in the TCSs (p = 0.04). When we evaluated GRISS subscores and depression levels, GRISS subscores of the TCSs who had high depression scores were also high. However, statistical significance was found in satisfaction (p = 0.009), touch (p = 0.04), avoidance (p = 0.01) and erectile dysfunction (p = 0.04) subscores in the TCSs. In the TCSs whose anxiety scores were high, emotional functioning (p = 0.009) and global QoL (p = 0.01) subscores of GRISS was found significantly low. In the TCSs whose depression scores were high, physical (p = 0.01), cognitive (p = 0.04), emotional (p = 0.03), social functioning (p = 0.02) and global QoL (p < 0.001) subscores of GRISS were found significantly low. Anxiety, depression and sexual satisfaction levels of TCSs were found to be similar with the control population.
Similar content being viewed by others
References
Shelley MD, Burgon K, Mason MD. Treatment of testicular germ-cell cancer: a Cochrane evidence-based systematic review. Cancer Treat Rev. 2002;28:237–53.
Nikzas D, Champion AE, Fox M. Germ cell tumors of testis: prognostic factors and results. Eur Urol. 1990;18:242–7.
Orre IJ, et al. Chronic cancer-related fatigue in long-term survivors of testicular cancer. J Psychosom Res. 2008;64(4):363–71.
Dahl A, Mykletun A, Fossa S. Quality of life in survivors of testicular cancer. Urol Oncol. 2005;23:193–200.
Fossa SD. Long-term sequelae after cancer therapy-survivorship after treatment for testicular cancer. Acta Oncol. 2004;43(2):134–41.
Harwas-Napierala B, Trempala J. (Human development psychology-Tom I.). Wydawnictwo Naukowe PWN; Warszawa. Psychologia rozwoju czlowieka. 2002.
Fegg MJ, Gerl A, Vollmer TC, Gruber U, Jost C, Meiler S, Hiddemann W. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br. Cancer. 2003;89(12):2202–6.
Jonker-Pool G, van de Wiel HB, Hoekstra HJ, Sleijfer DT, van Driel MF, van Basten JP. Schraffordt Koops HS. Sexual functioning after treatment for testicular cancer-review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav. 2001;30(1):55–74.
Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: a systematic review. J Psychosom Res. 2001;51(6):735–43.
Van Basten JP, Hoekstra HJ, van Driel MF, Schraffordt Koops HS, Droste JHJ, Jonker-Pool G, van de Wiel HB, Sleijfer DT. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy. J Clin Oncol. 1997;15(6):2442–8.
Van Basten JP, Jonker-Pool G, van Driel MF, Sleijfer DT, Droste JHJ, van de Wiel HB, Schraffordt Koops HS, Molenaar WM, Hoekstra HJ. Sexual functioning after multimodality treatment for disseminated nonseminomatous testicular germ-cell tumour. J Urol. 1997;158(4):1411–6.
Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:2389–95.
Manne S, Ostroff J, Sherman J, Glassman M, Ross S, Goldstein L, et al. Buffering effects of family and friend support on associations between partner unsupportive behaviors and coping among women with breast cancer. J Soc Pers Relat. 2003;20:771–92.
Rudberg L, Carlsson M, Nilsson S, et al. Self-perceived physical, psychologic and general symptoms in survivors of testicular cancer 3 to 13 years after treatment. Cancer Nurs. 2002;25:187–95.
Joly F, Heron J, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol. 2002;20:73–80.
Ozen H, Sahin A, Toklu C, et al. Psychosocial adjustment after testicular cancer treatment. J Urol. 1998;159:1947–50.
Kaasa S, Aass N, Mastekaasa A, et al. Psychosocial well-being in testicular cancer patients. Eur J Cancer. 1991;27:1091–5.
Arai Y, Kawakita M, Hida S, et al. Psychosocial aspects in long-term survivors of testicular cancer. J Urol. 1996;155:574–8.
Joly F, Heron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol. 2002;20:73–80.
Rust J, Golombok S. The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav. 1986;15:157–65.
Aydemir Ö. Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlilik ve güvenilirlik çalışması. Türk Psikiyatri Dergisi. 1997;8:280–7.
Rust J, Golombok S. The GRISS: a psychometric instrument for the assessment of sexual dysfunc-tion. Arch Sex Behav. 1986;15:157–65.
Tuğrul C, Öztan N, Kabakçı E. Golombok-Rust Cinsel Doyum Ölçeği’nin standardizasyon çalış-ması. Türk Psikiyatri Dergisi. 1993;4:83–8.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de HaesJC KS, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-c30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual, In third edition ed, 2001.
Moynihan C. Testicular Cancer: the psychosocial problems of patients and their relatives. Cancer Surv. 1987;6:477–510.
Jones GY, Payne S. Searching for safety signals: The experience of medical surveillance among men with testicular teratomas. Psychooncology 2000.
Fossa SD, Aass N, Ous S, et al. Long-term morbidity and quality of life in testicular cancer patients. Scand J Urol Nephrol. 1991;138:S241–6.
Jonker-Pool G, Van de Wiel HBM, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer–Review and meta-analysis of 36 empirical studies between 1975–2000. Arch Sex Behav. 2001;30(1):55–74.
Tinkler SD, Howard GCW, Kerr GR. Sexual morbidity following radiotherapy for germ cell tumors of the testis. Radiat Oncol. 1992;25(3):207–12.
Jonker-Pool G, van Basten JP, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer. Cancer. 1997;80(3):454–64.
Rieker PP, Fitzgerald EM, Kalish LA. Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol. 1990;8:347–55.
Heidenreich A, Hofmann R. Quality of Life issues in the treatment of testicular cancer. World J Urol. 1999;17(4):230–8.
Nord C, et al. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol. 2003;44(3):322–8.
Fegg M, et al. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer. 2003;89(12):2202–6.
Kuczyk M, et al. Sexual function and fertility after treatment of testicular cancer. Curr Opin Urol. 2000;10(5):473–7.
Fegg MJ, Gerl A, Vollmer TC. Subjective quality of life and sexual functioning after germ cell tumour therapy. Br J Cancer. 2003;89:2202–6.
Vidrine DJ, Gritz ER. Psychosocial outcomes after testicular cancer treatment. In: Steele Jr GD, Philips TL, Chabner BA, Gansler YS, editors. Germ cell tumours-American Cancer Society atlas of clinical oncology. Hamilton, London: BC Decker Ine; 2003. p. 295–305.
Jonker-Pool G, van-Basten JP, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer: comparison of treatment modalities. Cancer. 1997;80:454–64.
Fleer J, Hoekstra HJ, Sleijfer TD. Quality of life survivors of testicular germ cell cancer: a review of the literature. Support Care Cancer. 2004;12:476–86.
Mykletun A, Dahl CF, Haaland R, Bremnes O, Dahl O, Klepp E, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:3061–8.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alacacioglu, A., Ulger, E., Varol, U. et al. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Med Oncol 31, 43 (2014). https://doi.org/10.1007/s12032-014-0043-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-014-0043-3